Imatinib Tablets
Anticancer Medicine / Targeted Therapy
Imatinib Tablets
Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Imatinib Tablets (Imatikast). High-quality, reliable, affordable medicine.
Formulation
Tablets
Standard
WHO-GMP Certified Quality
Supply Type
Global Export & Institutional Supply
Finished Commercial Brand
Available finished formulation under our brand name Imatikast - 100.
View Commercial Product Details
WHO-GMP Certified
Global Export Ready
Quality Assured
Formulation Insights
Comprehensive Medical Overview
Imatinib Tablets
Classification: Anticancer Medicine / Targeted Therapy
About Imatinib Tablets
Imatinib is a breakthrough targeted cancer therapy used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GIST), and other specific malignancies by blocking the tyrosine kinase enzyme.
Imatinib Tablets (Imatikast) Manufactured by Aprazer Healthcare
Imatikast is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.